These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8630720)

  • 1. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.
    Okamoto LJ; Noonan M; DeBoisblanc BP; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 May; 76(5):455-61. PubMed ID: 8630720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.
    Mahajan P; Okamoto LJ; Schaberg A; Kellerman D; Schoenwetter WF
    J Asthma; 1997; 34(3):227-34. PubMed ID: 9168850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
    Sheffer AL; LaForce C; Chervinsky P; Pearlman D; Schaberg A
    J Fam Pract; 1996 Apr; 42(4):369-75. PubMed ID: 8627205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
    Noonan M; Chervinsky P; Busse WW; Weisberg SC; Pinnas J; de Boisblanc BP; Boltansky H; Pearlman D; Repsher L; Kellerman D
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1467-73. PubMed ID: 7582278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma.
    Nimmagadda SR; Spahn JD; Nelson HS; Jenkins J; Szefler SJ; Leung DY
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):35-40. PubMed ID: 9690571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC; Marone G; Di Maria GU; Visser S; Utama I; Payne SL
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
    Dahl R; Nielsen LP; Kips J; Foresi A; Cauwenberge P; Tudoric N; Howarth P; Richards DH; Williams M; Pauwels R;
    Allergy; 2005 Jul; 60(7):875-81. PubMed ID: 15932376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.